FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-112326.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.08-112326v1
22/12/4126    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Q.
Right arrow Articles by Quigg, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Q.
Right arrow Articles by Quigg, R. J.
(The FASEB Journal. 2008;22:4126-4135.)
© 2008 FASEB

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

Qiang Wang, Youli Wang, Andrew W. Minto, Jinhua Wang, Qun Shi, Xinmin Li and Richard J. Quigg1

The University of Chicago, Section of Nephrology, Department of Medicine, Chicago, Illinois, USA

1Correspondence: Section of Nephrology, The University of Chicago, 5841 South Maryland Ave., MC5100, AMB-S523, Chicago, IL 60637, USA. E-mail: rquigg{at}uchicago.edu

Intrinsic glomerular cells in a diabetic milieu have transcriptional activation of genes that influence the development of diabetic nephropathy. The cellular repertoire of microRNAs can regulate translation of these expressed genes into proteins. Fibronectin is a key matrix protein accumulated in excess in diabetic nephropathy. Here, we exposed cultured human and mouse mesangial cells to high glucose and transforming growth factor-β to simulate the diabetic milieu. In these conditions in vitro, as well as in mouse diabetic nephropathy models in vivo, microRNA-377 was consistently up-regulated relative to controls. Through a combination of computational and biological approaches, we identified relevant miR-377 target genes. Although fibronectin was induced by miR-377, it was not a direct target of miR-377. However, miR-377 led to reduced expressions of p21-activated kinase and superoxide dismutase, which enhanced fibronectin protein production. Thus, overexpression of miR-377 in diabetic nephropathy indirectly leads to increased fibronectin protein production; as such, miR-377 can have a critical role in the pathophysiology of this prevalent human disease.—Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., Quigg, R. J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.


Key Words: diabetes • microRNA • glomerulus • extracellular matrix




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. D. Cohen
Will non-coding RNAs help to decipher renal allograft failure?
Nephrol. Dial. Transplant., June 8, 2009; (2009) gfp274v1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.